Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 323 | 323 | 324 | 323 | 15,531 |
| Gross Profit | 323 | 323 | 324 | 323 | 15,531 |
| Operating Expenses | 16,392 | 23,931 | 31,396 | 33,478 | 36,129 |
| Operating Income | -16,069 | -23,608 | -31,072 | -33,155 | -20,598 |
| Interest Expense | 676 | 756 | 825 | 870 | 888 |
| Other Income | 20 | 58 | -16 | -60 | 6 |
| Pre-tax Income | -16,725 | -24,306 | -31,913 | -34,085 | -21,480 |
| Net Income Continuous | -16,725 | -24,306 | -31,913 | -34,085 | -21,480 |
| Net Income | $-16,725 | $-24,306 | $-31,913 | $-34,085 | $-21,480 |
| EPS Basic Total Ops | -3.20 | -4.70 | -6.20 | -6.90 | -5.00 |
| EPS Basic Continuous Ops | -3.17 | -4.72 | -6.22 | -6.90 | -4.93 |
| EPS Diluted Total Ops | -3.20 | -4.70 | -6.20 | -6.90 | -5.00 |
| EPS Diluted Continuous Ops | -3.17 | -4.72 | -6.22 | -6.90 | -4.93 |
| EBITDA(a) | $-14,962 | $-22,444 | $-29,766 | $-31,916 | $-19,556 |